Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D58AMF
|
|||
| Drug Name |
ABBV-CX-2029
|
|||
| Drug Type |
Antibody drug conjugate
|
|||
| Indication | Hematologic tumour [ICD-11: 2B33.Y] | Phase 1 | [1] | |
| Company |
AbbVie; CytomX Therapeutics
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Transferrin receptor protein 1 (TFRC) | Target Info | . | [1] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Clinical pipeline report, company report or official report of AbbVie. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.